172 related articles for article (PubMed ID: 37833632)
41. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195.
Wang QM; Lian GY; Song Y; Huang YF; Gong Y
Life Sci; 2019 Aug; 231():116335. PubMed ID: 30898647
[TBL] [Abstract][Full Text] [Related]
42. [Effect of MELK Inhibitor OTSSP167 on Diffuse Large B-Cell Lymphoma].
Zhou JY; Huang H; Zhuang Y; Zhong XM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):739-745. PubMed ID: 37356934
[TBL] [Abstract][Full Text] [Related]
43. Eukaryotic initiation factor 3a promotes the development of diffuse large B-cell lymphoma through regulating cell proliferation.
Sun H; Shang J; Liu X; Ren S; Hu S; Wang X
BMC Cancer; 2024 Apr; 24(1):432. PubMed ID: 38589831
[TBL] [Abstract][Full Text] [Related]
44. [Potential mechanism and prognostic value of promoter methylation of PRDM1 gene in diffuse large B cell lymphoma].
Zhang XY; Ma ZP; Cui WL; Chen R; Glinaer A; Miao N; Li XX
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):831-837. PubMed ID: 28056297
[No Abstract] [Full Text] [Related]
45. MicroRNA-26a/cyclin-dependent kinase 5 axis controls proliferation, apoptosis and in vivo tumor growth of diffuse large B-cell lymphoma cell lines.
Farina FM; Inguscio A; Kunderfranco P; Cortesi A; Elia L; Quintavalle M
Cell Death Dis; 2017 Jun; 8(6):e2890. PubMed ID: 28640256
[TBL] [Abstract][Full Text] [Related]
46. Downregulation of Cdc6 inhibits tumorigenesis of osteosarcoma in vivo and in vitro.
Jiang W; Yu Y; Liu J; Zhao Q; Wang J; Zhang J; Dang X
Biomed Pharmacother; 2019 Jul; 115():108949. PubMed ID: 31100539
[TBL] [Abstract][Full Text] [Related]
47. miR‑101 regulates the cell proliferation and apoptosis in diffuse large B‑cell lymphoma by targeting MEK1 via regulation of the ERK/MAPK signaling pathway.
Huang Y; Zou Y; Lin L; Ma X; Zheng R
Oncol Rep; 2019 Jan; 41(1):377-386. PubMed ID: 30365139
[TBL] [Abstract][Full Text] [Related]
48. [Effects of 2-12alkyl-6-methoxycyclohexa-2, 5-diene-1, 4-dione(DMDD)on diffuse large B lymphoma and its mechanism].
Hong K; Jiang PR; Ke RJ; Ying JH; Zhang XY; Chen JY
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2019 Jul; 35(4):312-316. PubMed ID: 31701713
[TBL] [Abstract][Full Text] [Related]
49. MicroRNA-26a/b regulate DNA replication licensing, tumorigenesis, and prognosis by targeting CDC6 in lung cancer.
Zhang X; Xiao D; Wang Z; Zou Y; Huang L; Lin W; Deng Q; Pan H; Zhou J; Liang C; He J
Mol Cancer Res; 2014 Nov; 12(11):1535-46. PubMed ID: 25100863
[TBL] [Abstract][Full Text] [Related]
50. CircRNA_OTUD7A upregulates FOXP1 expression to facilitate the progression of diffuse large B-cell lymphoma via acting as a sponge of miR-431-5p.
Liu W; Lei L; Liu X; Ye S
Genes Genomics; 2021 Jun; 43(6):653-667. PubMed ID: 33830472
[TBL] [Abstract][Full Text] [Related]
51. Overexpression of OCT-1 gene is a biomarker of adverse prognosis for diffuse large B-cell lymphoma (DLBCL): data from a retrospective cohort of 77 Brazilian patients.
Gouveia GR; Ferreira SC; Siqueira SAC; de Pádua Covas Lage LA; Hallack Neto AE; de Oliveira Costa R; Pereira J
BMC Cancer; 2020 Oct; 20(1):1041. PubMed ID: 33121489
[TBL] [Abstract][Full Text] [Related]
52. LINC00857 contributes to proliferation and lymphomagenesis by regulating miR-370-3p/CBX3 axis in diffuse large B-cell lymphoma.
Huang Y; Lin Y; Song X; Wu D
Carcinogenesis; 2021 May; 42(5):733-741. PubMed ID: 33657224
[TBL] [Abstract][Full Text] [Related]
53. Mammalian target of rapamycin inhibition induces cell cycle arrest in diffuse large B cell lymphoma (DLBCL) cells and sensitises DLBCL cells to rituximab.
Wanner K; Hipp S; Oelsner M; Ringshausen I; Bogner C; Peschel C; Decker T
Br J Haematol; 2006 Sep; 134(5):475-84. PubMed ID: 16856892
[TBL] [Abstract][Full Text] [Related]
54. MiR-645 regulates the proliferation and apoptosis of diffuse large B-cell lymphoma by targeting DACH1.
Wang R; Shen J; Su N; Wang Q; Zhang M; Liu C
Hum Cell; 2020 Oct; 33(4):1091-1098. PubMed ID: 32529465
[TBL] [Abstract][Full Text] [Related]
55. Mad2 overexpression is associated with high cell proliferation and reduced disease-free survival in primary gastrointestinal diffuse large B-cell lymphoma.
Chen F; Liu S; Zhou Y; Shen H; Zuo X
Hematology; 2016 Aug; 21(7):399-403. PubMed ID: 27077767
[TBL] [Abstract][Full Text] [Related]
56. Spatio-temporal regulation of the human licensing factor Cdc6 in replication and mitosis.
Kalfalah FM; Berg E; Christensen MO; Linka RM; Dirks WG; Boege F; Mielke C
Cell Cycle; 2015; 14(11):1704-15. PubMed ID: 25875233
[TBL] [Abstract][Full Text] [Related]
57. Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.
Huang J; Guo P; Ma D; Lin X; Fang Q; Wang J
Int J Oncol; 2016 Jul; 49(1):253-64. PubMed ID: 27211510
[TBL] [Abstract][Full Text] [Related]
58. High expression of CDC6 is associated with accelerated cell proliferation and poor prognosis of epithelial ovarian cancer.
Deng Y; Jiang L; Wang Y; Xi Q; Zhong J; Liu J; Yang S; Liu R; Wang J; Huang M; Tang C; Su M
Pathol Res Pract; 2016 Apr; 212(4):239-46. PubMed ID: 26920249
[TBL] [Abstract][Full Text] [Related]
59. GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway.
Wang Z; Ran X; Qian S; Hou H; Dong M; Wu S; Ding M; Zhang Y; Zhang X; Zhang M; Chen Q
Arch Biochem Biophys; 2021 Oct; 710():108998. PubMed ID: 34280359
[TBL] [Abstract][Full Text] [Related]
60. The Effect of High CDC6 Levels on Predicting Poor Prognosis in Colorectal Cancer.
Yang C; Xie N; Luo Z; Ruan X; Zhang Y; Wang W; Huang Y
Chemotherapy; 2022; 67(1):47-56. PubMed ID: 35034031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]